West Pharmaceutical Services, Inc.: Business Overview, Financials & Competitive Analysis
West Pharmaceutical Services, Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Premium compounder with secular tailwinds from injectable drug demand and biologics growth, but premium valuation limits upside. With a market capitalization of $21.4B (as of May 2026), West demonstrates robust scale and financial strength. However, the company faces skepticism despite a 14.2% free-cash-flow margin due to modest sales.
What is West Pharmaceutical Services, Inc.'s industry? West Pharmaceutical Services, Inc. (westpharma.com) operates in Pharmaceuticals. AskCyborg classifies West Pharmaceutical Services, Inc. under Pharmaceuticals in its company registry.
West Pharmaceutical Services designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. In fi...
Cyborg Score thesis
Premium compounder with secular tailwinds from injectable drug demand and biologics growth, but premium valuation limits...
Read the full analyst-debate transcript →Get the Latest West Pharmaceutical Services, Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeWest Pharmaceutical Services, Inc. Overview
Pro stress-test →West Pharmaceutical Services designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. In fiscal year 2025, the company generated $3.07 billion in net sales. The firm is a critical supplier of elastomer-based packaging components, nonglass containers, and auto-injectors to pharmaceutical, biotech, and medical device manufacturers.
Strategic Profile
Pro stress-test →The company operates in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). Q1 2026 delivered 21% revenue growth and 47% higher adjusted EPS, driven by strong HVP component and biologics demand, with full-year guidance raised for both revenue and EPS. The company benefits from tailwinds in GLP-1 receptor agonists and large-molecule biologics demand.
Competitive Landscape
Pro stress-test →Competitors include Nipro, Terumo, Becton Dickinson and Company, GE HealthCare Technologies, and Baxter India. West maintains competitive advantages through its specialized elastomer formulations for injectable applications, integrated technical support services, and dominant market position in proprietary stoppers and seals for pharmaceutical packaging. The company's scale and R&D capabilities position it favorably against fragmented competitors.
Industry Context
West Pharmaceutical Services, Inc. operates in Pharmaceuticals.
Key facts
Headquarters: Exton, US · Revenue: $3.07B · Market cap: $21.4B